Early research (Phase 1)Study completedNCT02193113
What this trial is testing
A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME
Who this might be right for
Diabetic Macular Edema
KalVista Pharmaceuticals, Ltd. 14